Minerva Cardioangiologica 2018 February;66(1):124-5

DOI: 10.23736/S0026-4725.17.04523-6

language: English

Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome

Nicola MARCHITTO ¹ ✉, Francesco SINDONA ², Alessandra FABRIZIO ³, Monica MAUTI ³, Simona ANDREOZZI ⁴, Serenella DALMASO ¹, Gianfranco RAIMONDI ⁵

¹ Alfredo Fiorini Hospital, Terracina, Latina, Italy; ² Faculty of Internal Medicine, “Sapienza” University of Rome, Rome, Italy; ³ Department of Nursing Sciences, “Sapienza” University of Rome, Rome, Italy; ⁴ Faculty of Medicine and Surgery, “Sapienza” University of Rome, Rome, Italy; ⁵ Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Internal Medicine, “Sapienza” University of Rome, Rome, Italy

PDF

top of page

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

Minerva Cardioangiologica 2018 February;66(1):124-5

Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome

Publication History

Cite this article as

Corresponding author e-mail

Share